Clinical and non-clinical bioanalysis

Citoxlab offers solutions to your challenges

> Clinical and non-clinical bioanalysis

> Clinical pathology

> Immunology

> Genomics and miRNA

Citoxlab offers GLP-compliant bioanalytical analysis for non-clinical studies performed in-house and for studies conducted in a Sponsor’s facility. Analysis of plasma/serum or other biological matrices is performed to determine the concentration of the test substance for pharmacokinetic/toxicokinetic studies. Citoxlab performs method development for bioanalysis of new compounds or the transfer of existing methods. In each case, the method is fully validated according to GLP principles.

Atlanbio (, our clinical bioanalysis site, offers a large range of mass-spectrometry-based bioanalytical techniques, immunoassays, immunogenicity testing and pharmacokinetic analysis. All activities are GLP compliant.

Small molecules, peptides and metallic ions

  • LC-MS/MS and (LC) ICP/MS
  • GC/MS
  • HPLC and UFLC


  • Nephrotoxicity
  • Inflammation
  • Complement factors
  • Immunotoxicity
  • Hormones

Broad range of matrices

  • Plasma and whole blood
  • Urine
  • Tissues
  • Cerebro-spinal fluid
  • Ocular fluids

Therapeutic proteins and biomarkers

  • Ligand binding assay, ELISA, ECLA, RIA
  • Flow cytometry
  • Multiplex technology


  • Method development and validation
  • Method transfer
  • Non-GLP discovery studies
  • GLP-compliant regulatory studies
  • Preclinical and clinical trials
  • Biomarker follow-up
  • Pharmacokinetics
  • Toxicokinetics
  • ADME
  • Residues (VICH GL49)

ADME: radiolabelled studies

  • Radiopurity
  • Excretion
  • Kinetics
  • Tissue distribution
  • Liquid scintillation counting